A Canadian advisory panel recommends Vioxx to be returned to the market
They also want ibuprofen to be moved behind the counter so pharmacists can discuss with customers the risk of cardiovascular side effects.
ADVERTISEMENT
More in Uncategorized
Past Week
-
Retirement isn’t the end of medicine, it’s a second act [PODCAST]
-
The conflict of interest that discloses as nothing
-
Why the family medical history lives with women caregivers
-
Patient communication ends when the patient understands
-
Staying salaried may now be the riskier bet for doctors [PODCAST]
-
How CREST-2 changes asymptomatic carotid stenosis treatment
-
Past 6 Months
-
Why CDC opioid guidelines get the overdose data wrong
-
Retirement isn’t the end of medicine, it’s a second act [PODCAST]
-
Sensory processing in autism and the brain’s volume control
-
What maternity care deserts cost a town
-
Why medicine needs a national physician license now
-
A cold cost $945. The cost of primary care is broken.
-
Recent Posts
-
Staying salaried may now be the riskier bet for doctors [PODCAST]
-
Why I wrote an emergency medicine novel about 1 night
-
Health data privacy with AI starts before you press send
-
Oluyemisi Famuyiwa, MD, on fertility and PCOS: a KevinMD subscriber spotlight
-
AI and clinical judgment: why patients still trust doctors
-
Moral injury in medicine is an odyssey without Ithaca
-
Subscribe to KevinMD and never miss a story!
Get free updates delivered free to your inbox.
